Meta-Analysis
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 6044-6051
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.6044
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Flow diagram of the study selection.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Comparison of biological agents for induction of clinical response in moderate to severe active ulcerative colitis.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Forest plots of biological agents for induction of clinical response in moderate to severe active ulcerative colitis.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Comparison of biological agents for induction of clinical remission in moderate to severe active ulcerative colitis.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Forest plots of biological agents for induction of clinical remission in moderate to severe active ulcerative colitis.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Comparison of biological agents for induction of mucosal healing in moderate to severe active ulcerative colitis.
Figure 7
Open in New Tab Full Size Figure Download Figure
Figure 7 Forest plots of biological agents for induction of mucosal healing in moderate to severe active ulcerative colitis.
Figure 8
Open in New Tab Full Size Figure Download Figure
Figure 8 Comparison of serious adverse events of biological agents in moderate to severe active ulcerative colitis.
Figure 9
Open in New Tab Full Size Figure Download Figure
Figure 9 Forest plots of serious adverse events of biological agents in moderate to severe active ulcerative colitis.